SEC Charges Cassava Sciences Over Manipulated Alzheimers Trial Data, Company And Former Execs Agree To Pay Penalty
| SAVA Stock | USD 26.48 5.70 17.71% |
About 62% of Cassava Sciences' investor base is looking to short. The analysis of overall sentiment of trading Cassava Sciences stock suggests that many investors are alarmed at this time. The current market sentiment, together with Cassava Sciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Cassava Sciences stock news signals to limit their universe of possible portfolio assets.
Cassava |
Cassava Sciences and its executives face a 40 million SEC settlement over manipulated data in an Alzheimers drug trial, misleading investors with false claims of cognitive improvement and selective data reporting.
Read at benzinga.com
 |
Cassava Sciences Fundamental Analysis
We analyze Cassava Sciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cassava Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cassava Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Flow From Operations
Cash Flow From Operations Comparative Analysis
Cassava Sciences is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Cassava Sciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cassava Sciences stock to make a market-neutral strategy. Peer analysis of Cassava Sciences could also be used in its relative valuation, which is a method of valuing Cassava Sciences by comparing valuation metrics with similar companies.
Peers
Cassava Sciences Related Equities
| MDGL | Madrigal Pharmaceuticals | 5.53 | ||||
| MCRB | Seres Therapeutics | 5.48 | ||||
| KRYS | Krystal Biotech | 4.45 | ||||
| CVAC | CureVac NV | 3.91 | ||||
| VIR | Vir Biotechnology | 2.45 | ||||
| INMB | INmune Bio | 2.31 | ||||
| EXEL | Exelixis | 2.24 | ||||
| VKTX | Viking Therapeutics | 1.86 | ||||
| TGTX | TG Therapeutics | 1.51 | ||||
| AVXL | Anavex Life | 1.00 | ||||
| AXSM | Axsome Therapeutics | 0.50 | ||||
| BIVI | Biovie | 1.93 | ||||
| ANVS | Annovis Bio | 2.06 | ||||
| CGTX | Cognition Therapeutics | 2.27 | ||||
| RVPH | Reviva Pharmaceuticals | 8.06 | ||||
| BTAI | BioXcel Therapeutics | 10.53 |
Complementary Tools for Cassava Stock analysis
When running Cassava Sciences' price analysis, check to measure Cassava Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cassava Sciences is operating at the current time. Most of Cassava Sciences' value examination focuses on studying past and present price action to predict the probability of Cassava Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cassava Sciences' price. Additionally, you may evaluate how the addition of Cassava Sciences to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |